The report, released at the three-day BioAsia 2019 conference in Hyderabad on Monday, said that as many as 71% startups that participated in the survey .
By ET Bureau | Updated:
ThinkStock Photos
The startups surveyed said that owing to the challenges associated with partnering with bigger companies, they had collaborated with smaller or mid-sized companies with revenues of less than Rs 100 crore.
Raising funds, understanding regulatory processes and collaborating with bigger competitors are the key challenges that Indian life sciences and healthcare startups are facing, global consultancy firm EY said in a report titled ‘Life Sciences 4.0: Transforming Healthcare in India’ based on a survey.
The report, released at the three-day BioAsia 2019 conference in Hyderabad on Monday, said that as many as 71% startups that participated in the survey said that owing to the challenges associated with partnering with bigger companies, they had collaborated with smaller or mid-sized companies with revenues of less than Rs 100 crore.
EY surveyed 60 life sciences and healthcare startups in India to gauge their success factors, challenges, collaboration landscape, growth areas and digital maturity.
ETtech Deals Digest: Sarvam mega round lifts startup funding to $403 million this week, up 36% on-year
